Electroencephalogram Burst-suppression during Cardiopulmonary Bypass in Elderly Patients Mediates Postoperative Delirium.


Journal

Anesthesiology
ISSN: 1528-1175
Titre abrégé: Anesthesiology
Pays: United States
ID NLM: 1300217

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 30 4 2020
medline: 17 9 2020
entrez: 30 4 2020
Statut: ppublish

Résumé

Intraoperative burst-suppression is associated with postoperative delirium. Whether this association is causal remains unclear. Therefore, the authors investigated whether burst-suppression during cardiopulmonary bypass (CPB) mediates the effects of known delirium risk factors on postoperative delirium. This was a retrospective cohort observational substudy of the Minimizing ICU [intensive care unit] Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS) trial. The authors analyzed data from patients more than 60 yr old undergoing cardiac surgery (n = 159). Univariate and multivariable regression analyses were performed to assess for associations and enable causal inference. Delirium risk factors were evaluated using the abbreviated Montreal Cognitive Assessment and Patient-Reported Outcomes Measurement Information System questionnaires for applied cognition, physical function, global health, sleep, and pain. The authors also analyzed electroencephalogram data (n = 141). The incidence of delirium in patients with CPB burst-suppression was 25% (15 of 60) compared with 6% (5 of 81) in patients without CPB burst-suppression. In univariate analyses, age (odds ratio, 1.08 [95% CI, 1.03 to 1.14]; P = 0.002), lowest CPB temperature (odds ratio, 0.79 [0.66 to 0.94]; P = 0.010), alpha power (odds ratio, 0.65 [0.54 to 0.80]; P < 0.001), and physical function (odds ratio, 0.95 [0.91 to 0.98]; P = 0.007) were associated with CPB burst-suppression. In separate univariate analyses, age (odds ratio, 1.09 [1.02 to 1.16]; P = 0.009), abbreviated Montreal Cognitive Assessment (odds ratio, 0.80 [0.66 to 0.97]; P = 0.024), alpha power (odds ratio, 0.75 [0.59 to 0.96]; P = 0.025), and CPB burst-suppression (odds ratio, 3.79 [1.5 to 9.6]; P = 0.005) were associated with delirium. However, only physical function (odds ratio, 0.96 [0.91 to 0.99]; P = 0.044), lowest CPB temperature (odds ratio, 0.73 [0.58 to 0.88]; P = 0.003), and electroencephalogram alpha power (odds ratio, 0.61 [0.47 to 0.76]; P < 0.001) were retained as predictors in the burst-suppression multivariable model. Burst-suppression (odds ratio, 4.1 [1.5 to 13.7]; P = 0.012) and age (odds ratio, 1.07 [0.99 to 1.15]; P = 0.090) were retained as predictors in the delirium multivariable model. Delirium was associated with decreased electroencephalogram power from 6.8 to 24.4 Hertz. The inference from the present study is that CPB burst-suppression mediates the effects of physical function, lowest CPB temperature, and electroencephalogram alpha power on delirium.

Sections du résumé

BACKGROUND
Intraoperative burst-suppression is associated with postoperative delirium. Whether this association is causal remains unclear. Therefore, the authors investigated whether burst-suppression during cardiopulmonary bypass (CPB) mediates the effects of known delirium risk factors on postoperative delirium.
METHODS
This was a retrospective cohort observational substudy of the Minimizing ICU [intensive care unit] Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS) trial. The authors analyzed data from patients more than 60 yr old undergoing cardiac surgery (n = 159). Univariate and multivariable regression analyses were performed to assess for associations and enable causal inference. Delirium risk factors were evaluated using the abbreviated Montreal Cognitive Assessment and Patient-Reported Outcomes Measurement Information System questionnaires for applied cognition, physical function, global health, sleep, and pain. The authors also analyzed electroencephalogram data (n = 141).
RESULTS
The incidence of delirium in patients with CPB burst-suppression was 25% (15 of 60) compared with 6% (5 of 81) in patients without CPB burst-suppression. In univariate analyses, age (odds ratio, 1.08 [95% CI, 1.03 to 1.14]; P = 0.002), lowest CPB temperature (odds ratio, 0.79 [0.66 to 0.94]; P = 0.010), alpha power (odds ratio, 0.65 [0.54 to 0.80]; P < 0.001), and physical function (odds ratio, 0.95 [0.91 to 0.98]; P = 0.007) were associated with CPB burst-suppression. In separate univariate analyses, age (odds ratio, 1.09 [1.02 to 1.16]; P = 0.009), abbreviated Montreal Cognitive Assessment (odds ratio, 0.80 [0.66 to 0.97]; P = 0.024), alpha power (odds ratio, 0.75 [0.59 to 0.96]; P = 0.025), and CPB burst-suppression (odds ratio, 3.79 [1.5 to 9.6]; P = 0.005) were associated with delirium. However, only physical function (odds ratio, 0.96 [0.91 to 0.99]; P = 0.044), lowest CPB temperature (odds ratio, 0.73 [0.58 to 0.88]; P = 0.003), and electroencephalogram alpha power (odds ratio, 0.61 [0.47 to 0.76]; P < 0.001) were retained as predictors in the burst-suppression multivariable model. Burst-suppression (odds ratio, 4.1 [1.5 to 13.7]; P = 0.012) and age (odds ratio, 1.07 [0.99 to 1.15]; P = 0.090) were retained as predictors in the delirium multivariable model. Delirium was associated with decreased electroencephalogram power from 6.8 to 24.4 Hertz.
CONCLUSIONS
The inference from the present study is that CPB burst-suppression mediates the effects of physical function, lowest CPB temperature, and electroencephalogram alpha power on delirium.

Identifiants

pubmed: 32349072
doi: 10.1097/ALN.0000000000003328
pmc: PMC7365754
mid: NIHMS1580078
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

280-292

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS102190
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG053582
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102574
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS090900
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107291
Pays : United States

Commentaires et corrections

Type : CommentOn
Type : CommentIn
Type : CommentIn

Références

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1696-702
pubmed: 24774439
Am J Geriatr Psychiatry. 2013 Dec;21(12):1190-222
pubmed: 24206937
J Am Geriatr Soc. 2017 Aug;65(8):e109-e116
pubmed: 28555781
Neurobiol Aging. 2019 Feb;74:112-120
pubmed: 30448611
N Engl J Med. 2006 Mar 16;354(11):1157-65
pubmed: 16540616
Crit Care Med. 2018 Dec;46(12):e1204-e1212
pubmed: 30222634
Clin Neurophysiol. 2019 Jan;130(1):55-60
pubmed: 30476711
J Am Geriatr Soc. 2019 Aug;67(8):1610-1616
pubmed: 30934109
Br J Sports Med. 2015 Feb;49(4):248-54
pubmed: 24711660
Br J Anaesth. 2018 Jul;121(1):241-248
pubmed: 29935578
Eur J Prev Cardiol. 2018 Mar;25(4):404-417
pubmed: 29338307
PLoS One. 2013 Oct 25;8(10):e78163
pubmed: 24205142
Ageing Res Rev. 2016 Jan;25:13-23
pubmed: 26607411
Neuropsychopharmacology. 1997 Apr;16(4):269-75
pubmed: 9094144
World J Surg. 2019 Jul;43(7):1661-1668
pubmed: 30788536
J Neurosci. 2017 Jul 19;37(29):6938-6945
pubmed: 28626012
Anesthesiology. 2017 Aug;127(2):293-306
pubmed: 28657957
Ann Surg. 2011 Jun;253(6):1223-9
pubmed: 21412145
Brain Res. 2019 Mar 15;1707:154-163
pubmed: 30496734
Anesth Analg. 2016 Aug;123(2):430-5
pubmed: 27096563
Neuroscience. 2019 Feb 21;400:146-156
pubmed: 30599265
Neurology. 2019 Feb 26;92(9):e905-e916
pubmed: 30700591
Eur J Surg Oncol. 2018 May;44(5):594-599
pubmed: 29459017
Stroke. 2013 Jan;44(1):227-9
pubmed: 23138443
Anaesthesia. 2013 Jan;68(1):67-73
pubmed: 23121372
Anesthesiology. 2017 Mar;126(3):419-430
pubmed: 28092321
Alzheimers Dement. 2016 Jul;12(7):766-75
pubmed: 27103261
Aging Clin Exp Res. 2018 Jan;30(1):27-34
pubmed: 28243862
Front Syst Neurosci. 2017 May 30;11:38
pubmed: 28611601
J Neurosci. 2001 Mar 1;21(5):1628-34
pubmed: 11222653
JAMA. 2019 Feb 5;321(5):473-483
pubmed: 30721296
Front Syst Neurosci. 2017 May 08;11:24
pubmed: 28533746
Curr Opin Neurobiol. 2017 Jun;44:178-185
pubmed: 28544930
Epilepsia. 2002 Feb;43(2):146-53
pubmed: 11903460
PLoS One. 2017 Jul 10;12(7):e0180641
pubmed: 28700610
Epilepsy Curr. 2006 Jul-Aug;6(4):119-20
pubmed: 17260031
Psychopharmacology (Berl). 2000 Mar;149(1):6-11
pubmed: 10789876
Anesth Analg. 2016 Jan;122(1):234-42
pubmed: 26418126
Anesthesiology. 2017 Nov;127(5):765-774
pubmed: 28891828
BMC Anesthesiol. 2015 Apr 28;15:61
pubmed: 25928189
J Appl Physiol (1985). 2008 Nov;105(5):1585-94
pubmed: 18801961
Anesthesiology. 2017 Jul;127(1):78-88
pubmed: 28459734
BMJ Open. 2018 Apr 20;8(4):e020316
pubmed: 29678977
Ann Intern Med. 2018 Jan 2;168(1):30-38
pubmed: 29255839
Br J Anaesth. 2010 Sep;105(3):297-303
pubmed: 20573634
Ageing Res Rev. 2017 Nov;40:75-83
pubmed: 28912076
Lancet. 2014 Mar 8;383(9920):911-22
pubmed: 23992774
J Gerontol A Biol Sci Med Sci. 2017 Jun 1;72(6):789-795
pubmed: 27422439
Clin Neurophysiol. 2016 Jun;127(6):2472-81
pubmed: 27178867

Auteurs

Juan C Pedemonte (JC)

From the Departments of Anesthesia, Critical Care, and Pain Medicine (J.C.P., G.S.P., S.C., E.H., B.E., J.G., R.I., J.M., K.M.C., T.H., K.T.S., J.Q., O.A.) Department of Neurology (J.J.L., M.B.W.) Department of Surgery, Division of Cardiac Surgery (D.A.D., G.T.) Henry and Allison McCance Center for Brain Health (M.B.W., O.A.) Clinical Data Animation Center (M.B.W.), Massachusetts General Hospital, Boston, Massachusetts Department of Anesthesiology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile (J.C.P.) Tufts University School of Medicine, Boston, Massachusetts (G.S.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH